Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from a nationwide Swedish register. [electronic resource]
Producer: 20200317Description: 1507 p. digitalISSN:- 1462-0332
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.